Core Viewpoint - The market anticipates a year-over-year decline in Pembina Pipeline's earnings despite higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Pembina Pipeline is expected to report earnings of $0.47 per share, reflecting a year-over-year decrease of 14.6%, while revenues are projected to be $1.64 billion, an increase of 21% from the previous year [3]. - The earnings report is scheduled for August 7, and better-than-expected results could lead to a stock price increase, whereas disappointing results may cause a decline [2]. Estimate Revisions - The consensus EPS estimate has been revised down by 1.44% over the last 30 days, indicating a reassessment by analysts [4]. - Pembina Pipeline's Earnings ESP is currently 0%, suggesting no recent differing analyst views from the consensus estimate [12]. Historical Performance - In the last reported quarter, Pembina Pipeline was expected to post earnings of $0.57 per share but delivered $0.56, resulting in a surprise of -1.75% [13]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [14]. Industry Comparison - In the same industry, Williams Companies is expected to report earnings of $0.49 per share, a year-over-year increase of 14%, with revenues projected at $3.06 billion, up 30.9% from the previous year [18][19]. - Williams Companies has a positive Earnings ESP of +0.15% and has consistently beaten consensus EPS estimates in the last four quarters [20].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Pagaya Technologies Ltd. due to higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The upcoming earnings report is expected to show quarterly earnings of $0.69 per share, reflecting a +590% change year-over-year, and revenues of $323.83 million, which is a 29.4% increase from the previous year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their initial estimates during this period [4]. Earnings Surprise Prediction - Pagaya Technologies Ltd. has a positive Earnings ESP of +2.19%, suggesting analysts are optimistic about the company's earnings prospects, combined with a Zacks Rank of 1 indicating a strong likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Pagaya Technologies Ltd. exceeded the expected earnings of $0.4 per share by delivering $0.69, resulting in a surprise of +72.50%. Over the last four quarters, the company has beaten consensus EPS estimates two times [13][14]. Conclusion - Pagaya Technologies Ltd. is positioned as a compelling candidate for an earnings beat, although investors should consider additional factors beyond earnings results when making investment decisions [17].

Core Viewpoint - Martin Marietta (MLM) is expected to report a year-over-year increase in earnings and revenues for the quarter ended June 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus estimate for quarterly earnings is $5.30 per share, reflecting a +0.8% change year-over-year, while revenues are anticipated to be $1.88 billion, up 6.5% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 0.45% lower in the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a positive Earnings ESP of +0.20% for Martin Marietta, suggesting a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Martin Marietta had an expected EPS of $1.94 but delivered $1.90, resulting in a surprise of -2.06%. Over the last four quarters, the company has only beaten consensus EPS estimates once [13][14]. Investment Considerations - While a potential earnings beat is a positive indicator, other factors may influence stock performance, making it essential to consider the broader context [15][17].

Core Viewpoint - RXO is anticipated to report a year-over-year decline in earnings despite an increase in revenues, which could significantly influence its stock price in the near term [1][2]. Earnings Expectations - The upcoming earnings report is expected to show quarterly earnings of $0.02 per share, reflecting a year-over-year decrease of 33.3% [3]. - Revenues are projected to reach $1.45 billion, representing a 56% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 10.53% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for RXO is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +50.00% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive reading indicates a likely earnings beat, particularly when combined with a strong Zacks Rank [10]. - RXO currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat despite the positive Earnings ESP [12]. Historical Performance - In the last reported quarter, RXO was expected to post a loss of $0.02 per share but actually reported a loss of $0.03, resulting in a surprise of -50.00% [13]. - Over the past four quarters, RXO has only beaten consensus EPS estimates once [14]. Conclusion - RXO does not appear to be a strong candidate for an earnings beat, and investors should consider additional factors when evaluating the stock ahead of the earnings release [17].

Core Viewpoint - Somnigroup International (SGI) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ended June 2025, with the actual results being crucial for the stock price movement [1][2]. Earnings Expectations - The upcoming earnings report is expected to show earnings of $0.51 per share, reflecting a year-over-year decrease of 19.1%, while revenues are projected to reach $1.88 billion, marking a 52.2% increase from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 1.34% higher in the last 30 days, indicating a collective reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that the Most Accurate Estimate for SGI is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +2.97%, indicating a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, SGI exceeded the expected earnings of $0.47 per share by delivering $0.49, achieving a surprise of +4.26%. Over the last four quarters, the company has beaten consensus EPS estimates three times [13][14]. Investment Considerations - While a potential earnings beat is a positive indicator, other factors may influence stock performance, and it is essential to consider the Earnings ESP and Zacks Rank before making investment decisions [15][16][17].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for The Beauty Health Company (SKIN) despite lower revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The upcoming earnings report is expected to show a quarterly loss of $0.06 per share, reflecting a 40% improvement year-over-year, while revenues are projected at $74.55 million, down 17.7% from the previous year [3]. - A positive earnings surprise could lead to a stock price increase, while a miss may result in a decline [2]. Estimate Revisions - The consensus EPS estimate has been revised 3.85% higher in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Beauty Health is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +20.00% [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Beauty Health currently holds a Zacks Rank of 2, indicating a favorable outlook for beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Beauty Health was expected to post a loss of $0.13 per share but actually reported a loss of $0.08, resulting in a surprise of +38.46% [13]. - Over the past four quarters, the company has exceeded consensus EPS estimates twice [14]. Conclusion - While the potential for an earnings beat exists, other factors may also influence stock performance, making it essential to consider the broader context [15][17].

The earnings report, which is expected to be released on August 7, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower. While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise. Zacks Consensus Estimate This holding company is expect ...

Wall Street expects a year-over-year decline in earnings on higher revenues when StepStone Group Inc. (STEP) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on Augus ...

Estimate Revisions Trend The consensus EPS estimate for the quarter has been revised 15.15% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Turtle Beach (TBCH) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Trupanion (TRUP) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 7. On th ...